Rocket Lab shares jumped 8.2% after Cantor Fitzgerald reiterated its Overweight rating and $122 price target. Investors are focusing on the company’s upcoming Neutron rocket launch, the planned Iridium acquisition and a record $2.36 billion backlog.
Market Samachar is a news aggregator. This article was originally published by Markets-Economic Times. Tap the button above to read the full story on their site.